Industry Developments
In recent months, the UK Medical Device Second Opinion Market has witnessed notable developments influenced by advancements in technology and regulatory updates. Companies like Medtronic, Philips, and Boston Scientific have expanded their offerings, focusing on artificial intelligence-driven diagnostics and telemedicine solutions, which enhance the second opinion process. Merger discussions have intensified, notably impacting market dynamics; for instance, in March 2023, Baxter International announced its acquisition of a smaller UK-based digital health firm aimed at integrating remote monitoring services, while Siemens Healthineers completed its acquisition of a software company to improve imaging services in medical device evaluations. Furthermore, the market is projected to grow significantly due to increasing investments in healthcare infrastructure, bolstered by the UK government’s commitment to enhance digital health capabilities as outlined in its Long Term Plan in January 2022. This trend is further supported by substantial funding allocations for innovation in the medical device sector. Additionally, regulatory changes are promoting quick access to second opinion services, reflecting the growing need for expert consultations in a time-efficient manner amidst the ongoing evolution of healthcare delivery in the UK.
Report Scope
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 0.29(USD Billion) |
| MARKET SIZE 2024 | 0.34(USD Billion) |
| MARKET SIZE 2035 | 1.47(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 14.31% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Billion |
| KEY COMPANIES PROFILED | Baxter International, Olympus Corporation, Medtronic, Philips, Johnson and Johnson, Boston Scientific, Siemens Healthineers, Thermo Fisher Scientific, Cardinal Health, Fresenius SE, B. Braun, Zimmer Biomet, GE Healthcare, Abbott Laboratories, Stryker |
| SEGMENTS COVERED | Application Outlook, Source of Service Outlook, Services Outlook, Type Outlook |
| KEY MARKET OPPORTUNITIES | Telehealth integration advancements, Growing demand for remote consultations, Increasing patient awareness and education, Regulatory support for second opinions, Rising trend of personalized medicine |
| KEY MARKET DYNAMICS | increasing patient empowerment, growing telemedicine adoption, rising prevalence of chronic diseases, regulatory compliance pressure, demand for personalized healthcare solutions |
| COUNTRIES COVERED | UK |
FAQs
What is the expected market size of the UK Medical Device Second Opinion Market in 2024?
The UK Medical Device Second Opinion Market is expected to be valued at 0.34 USD Billion in 2024.
How fast is the UK Medical Device Second Opinion Market projected to grow?
The market is projected to grow at a CAGR of 14.31% from 2025 to 2035.
What will be the market size of the UK Medical Device Second Opinion Market by 2035?
By 2035, the market is expected to be valued at 1.47 USD Billion.
What application segments are driving the UK Medical Device Second Opinion Market?
Key application segments include Cancer, Diabetes, Cardiac Disorders, Neurological Disorders, and Respiratory Disorders.
What is the market size for Cancer applications in the UK Medical Device Second Opinion Market in 2024?
The market size for Cancer applications is valued at 0.08 USD Billion in 2024.
Which companies are the key players in the UK Medical Device Second Opinion Market?
Major players in this market include Baxter International, Medtronic, Phillips, and Boston Scientific among others.
What is the projected market size for Diabetes applications by 2035?
The projected market size for Diabetes applications is expected to be 0.25 USD Billion by 2035.
What are the expected financial figures for Cardiac Disorders in 2024?
The market for Cardiac Disorders is expected to be valued at 0.07 USD Billion in 2024.
How significant is the market opportunity for Neurological Disorders by 2035?
The market is anticipated to reach 0.39 USD Billion for Neurological Disorders by 2035.
What is the market value for Respiratory Disorders in 2024?
The market value for Respiratory Disorders is projected to be 0.04 USD Billion in 2024.
Kindly complete the form below to receive a free sample of this Report
Customer Stories
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
Leave a Comment